2017
DOI: 10.1038/cmi.2017.66
|View full text |Cite
|
Sign up to set email alerts
|

Clonal expansion shapes the human Vδ1T cell receptor repertoire

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…Based on their cytokine production, γδT cells are usually divided into two subsets: γδT1 and γδT17 cells ( 40 ). Human γδT cells are usually divided into two major structural subsets according to their TCRδ chain usage: Vδ1 and Vδ2 T cells ( 28 , 41 ). The majority of liver resident γδT cells in human chronic liver disease were Vδ2 − γδT cells, which mainly produce cytokines IFNγ and TNFα ( 42 ).…”
Section: Discussionmentioning
confidence: 99%
“…Based on their cytokine production, γδT cells are usually divided into two subsets: γδT1 and γδT17 cells ( 40 ). Human γδT cells are usually divided into two major structural subsets according to their TCRδ chain usage: Vδ1 and Vδ2 T cells ( 28 , 41 ). The majority of liver resident γδT cells in human chronic liver disease were Vδ2 − γδT cells, which mainly produce cytokines IFNγ and TNFα ( 42 ).…”
Section: Discussionmentioning
confidence: 99%
“…Vδ1 T cells are a subpopulation with strong antitumor activity that are expected to be used in tumor immunotherapy. They can be activated by a variety of ligands, such as stress-induced autoantigens, glycolipid antigens presented by CD1d, and various potentially undiscovered ligands [112,113]. Compared with Vγ9Vδ2 T cells, Vδ1 T cells do not depend on N-BPs for their activation.…”
Section: γδ T Cell-based Cancer Immunotherapymentioning
confidence: 99%